22nd Century Gross Profit 2012-2026 | XXII
22nd Century gross profit from 2012 to 2026. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
|
22nd Century Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2025 | $-3 |
| 2024 | $-2 |
| 2023 | $-9 |
| 2022 | $2 |
| 2021 | $1 |
| 2020 | $1 |
| 2019 | $0 |
| 2018 | $1 |
| 2017 | $-1 |
| 2016 | $0 |
| 2015 | $-1 |
| 2014 | $0 |
| 2013 | $7 |
| 2012 | $0 |
| 2011 | $1 |
|
22nd Century Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2026-03-31 | $-1 |
| 2025-12-31 | $-1 |
| 2025-09-30 | $-1 |
| 2025-06-30 | $-1 |
| 2025-03-31 | $-1 |
| 2024-12-31 | $-1 |
| 2024-09-30 | $-1 |
| 2024-06-30 | $1 |
| 2024-03-31 | $-1 |
| 2023-12-31 | $-8 |
| 2023-09-30 | $0 |
| 2023-06-30 | $-1 |
| 2023-03-31 | $0 |
| 2022-12-31 | $0 |
| 2022-09-30 | $1 |
| 2022-06-30 | $1 |
| 2022-03-31 | $0 |
| 2021-12-31 | $0 |
| 2021-09-30 | $0 |
| 2021-06-30 | $0 |
| 2021-03-31 | $1 |
| 2020-12-31 | $1 |
| 2020-09-30 | $0 |
| 2020-06-30 | $0 |
| 2020-03-31 | $0 |
| 2019-12-31 | $0 |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| 2019-03-31 | $0 |
| 2018-12-31 | $1 |
| 2018-09-30 | $0 |
| 2018-06-30 | $0 |
| 2018-03-31 | $0 |
| 2017-12-31 | $0 |
| 2017-09-30 | $0 |
| 2017-06-30 | $0 |
| 2017-03-31 | $0 |
| 2016-12-31 | $0 |
| 2016-09-30 | $0 |
| 2016-06-30 | $0 |
| 2016-03-31 | $0 |
| 2015-12-31 | $0 |
| 2015-09-30 | $0 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | $0 |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | $7 |
| 2013-09-30 | $0 |
| 2013-06-30 | |
| 2013-03-31 | |
| 2012-12-31 | $0 |
| 2012-09-30 | $0 |
| 2012-06-30 | |
| 2012-03-31 | |
| 2011-12-31 | $0 |
| 2011-09-30 | $0 |
| 2011-06-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Consumer Staples | Tobacco Products | $0.001B | $0.018B |
| 22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Philip Morris (PM) | United States | $250.066B | 21.28 |
| British American Tobacco (BTI) | United Kingdom | $120.087B | 0.00 |
| Altria (MO) | United States | $112.613B | 12.43 |
| JAPAN TOB (JAPAY) | Japan | $66.869B | 20.69 |
| Imperial Tobacco Group (IMBBY) | United Kingdom | $32.506B | 0.00 |
| Turning Point Brands (TPB) | United States | $1.616B | 26.70 |
| Universal (UVV) | United States | $1.332B | 13.73 |
| Ispire Technology (ISPR) | United States | $0.100B | 0.00 |
| Charlie's Holdings (CHUC) | United States | $0.066B | 24.20 |